Berberine ES-5 60 C by Xymogen
Berberine ES-5 60 C by Xymogen is a dietary supplement formulated to support healthy blood glucose metabolism.* Due to containing a special metabolite of berberine, the formula offers a fivefold increase in bioavailability compared to standard berberine, making it a more efficient option for individuals seeking metabolic support.* This supplement combines traditional herbal wisdom with modern scientific research to provide a potent tool for maintaining healthy glucose metabolism.*
Who Should Consider Berberine ES-5?
Berberine ES-5 may support your health if you:
- want to promote healthy blood glucose metabolism,*
- prefer a highly bioavailable form of berberine for enhanced absorption,*
- seek a supplement that incorporates traditional herbal ingredients with modern clinical research*
Berberine ES-5—Effects?
Berberine ES-5 may have the following effects:
- supports glucose metabolism,*
- enhances insulin sensitivity and glucose tolerance,*
- helps regulate lipid metabolism and gut microbiota balance*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about Berberine ES-5.
Recommendation:
Xymogen suggests taking 1 Berberine ES-5 capsule per day or as recommended by your healthcare professional.
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518
References:
- Feng R, Shou JW, Zhao ZX, et al. Sci Rep. 2015;5:12155. doi:10.1038/srep12155
- Imenshahidi M, Hosseinzadeh H. Phytother Res. 2019;33(3):504-523. doi:10.1002/ptr.6252
- Moon J, Ratliff K, Hagele A, et al. Nutrients. 2021;14(1):124. doi:10.3390/nu14010124
- Zhang Q, Xiao X, Feng K, et al. Evid Based Complement Alternat Med. 2011;2011:924851. doi:10.1155/2011/924851